Ju-Tao Guo, MD

Chief Scientific Officer

Dr. Guo is Senior Vice President for Research and the W. Thomas London Professor at the Baruch S. Blumberg Institute. He has been working on molecular virology and antiviral research of hepatitis viruses, flaviviruses and human coronaviruses for decades. Dr. Guo’s current research efforts are primarily focused on investigation of hepatitis B virus (HBV) cccDNA biology and identification of molecular targets for therapeutic elimination or inactivation of cccDNA to cure chronic hepatitis B. His previous work led to some of the first HBV capsid inhibitor and is co-inventor of MERLIN Biotech’s hepatitis B and liver cancer technologies. Dr. Guo is one of the nation’s leading HBV virologists.